Literature DB >> 17114003

A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.

Martijn Verdoes1, Bogdan I Florea, Victoria Menendez-Benito, Christa J Maynard, Martin D Witte, Wouter A van der Linden, Adrianus M C H van den Nieuwendijk, Tanja Hofmann, Celia R Berkers, Fijs W B van Leeuwen, Tom A Groothuis, Michiel A Leeuwenburgh, Huib Ovaa, Jacques J Neefjes, Dmitri V Filippov, Gijs A van der Marel, Nico P Dantuma, Herman S Overkleeft.   

Abstract

The proteasome is an essential evolutionary conserved protease involved in many regulatory systems. Here, we describe the synthesis and characterization of the activity-based, fluorescent, and cell-permeable inhibitor Bodipy TMR-Ahx(3)L(3)VS (MV151), which specifically targets all active subunits of the proteasome and immunoproteasome in living cells, allowing for rapid and sensitive in-gel detection. The inhibition profile of a panel of commonly used proteasome inhibitors could be readily determined by MV151 labeling. Administration of MV151 to mice allowed for in vivo labeling of proteasomes, which correlated with inhibition of proteasomal degradation in the affected tissues. This probe can be used for many applications ranging from clinical profiling of proteasome activity, to biochemical analysis of subunit specificity of inhibitors, and to cell biological analysis of the proteasome function and dynamics in living cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114003     DOI: 10.1016/j.chembiol.2006.09.013

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  65 in total

1.  A panel of subunit-selective activity-based proteasome probes.

Authors:  Martijn Verdoes; Lianne I Willems; Wouter A van der Linden; Boudewijn A Duivenvoorden; Gijsbert A van der Marel; Bogdan I Florea; Alexei F Kisselev; Herman S Overkleeft
Journal:  Org Biomol Chem       Date:  2010-05-06       Impact factor: 3.876

2.  Nature of pharmacophore influences active site specificity of proteasome inhibitors.

Authors:  Michael Screen; Matthew Britton; Sondra L Downey; Martijn Verdoes; Mathias J Voges; Annet E M Blom; Paul P Geurink; Martijn D P Risseeuw; Bogdan I Florea; Wouter A van der Linden; Alexandre A Pletnev; Herman S Overkleeft; Alexei F Kisselev
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

Review 3.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

4.  Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS.

Authors:  Nan Li; Chi-Lin Kuo; Guillem Paniagua; Hans van den Elst; Martijn Verdoes; Lianne I Willems; Wouter A van der Linden; Mark Ruben; Eric van Genderen; Jacob Gubbens; Gilles P van Wezel; Herman S Overkleeft; Bogdan I Florea
Journal:  Nat Protoc       Date:  2013-05-23       Impact factor: 13.491

5.  Proteasome activity imaging and profiling characterizes bacterial effector syringolin A.

Authors:  Izabella Kolodziejek; Johana C Misas-Villamil; Farnusch Kaschani; Jérôme Clerc; Christian Gu; Daniel Krahn; Sherry Niessen; Martijn Verdoes; Lianne I Willems; Hermen S Overkleeft; Markus Kaiser; Renier A L van der Hoorn
Journal:  Plant Physiol       Date:  2010-11-02       Impact factor: 8.340

Review 6.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

7.  Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.

Authors:  Christa J Maynard; Claudia Böttcher; Zaira Ortega; Ruben Smith; Bogdan I Florea; Miguel Díaz-Hernández; Patrik Brundin; Hermen S Overkleeft; Jia-Yi Li; Jose J Lucas; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

8.  Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors.

Authors:  Wenhu Zhan; Joseph Visone; Tierra Ouellette; Jacob C Harris; Rong Wang; Hao Zhang; Pradeep K Singh; John Ginn; George Sukenick; Tzu-Tshin Wong; Judith I Okoro; Ryan M Scales; Patrick K Tumwebaze; Philip J Rosenthal; Björn F C Kafsack; Roland A Cooper; Peter T Meinke; Laura A Kirkman; Gang Lin
Journal:  J Med Chem       Date:  2019-06-20       Impact factor: 7.446

9.  Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites.

Authors:  Paul P Geurink; Wouter A van der Linden; Anne C Mirabella; Nerea Gallastegui; Gerjan de Bruin; Annet E M Blom; Mathias J Voges; Elliot D Mock; Bogdan I Florea; Gijs A van der Marel; Christoph Driessen; Mario van der Stelt; Michael Groll; Herman S Overkleeft; Alexei F Kisselev
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

10.  Application of activity-based protein profiling to study enzyme function in adipocytes.

Authors:  Andrea Galmozzi; Eduardo Dominguez; Benjamin F Cravatt; Enrique Saez
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.